2020
An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study.
Fucito LM, Wu R, O'Malley SS, Hanrahan TH, Ikomi JT, Muvvala S, Carroll KM, Gueorguieva R. An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study. The Journal Of Smoking Cessation 2020, 15: 119-127. PMID: 33312238, PMCID: PMC7731353, DOI: 10.1017/jsc.2020.13.Peer-Reviewed Original ResearchFeasibility/acceptabilityHeavy drinking smokersAlcohol counsellingHeavy drinkingBehavioral interventionsPilot studyOpen-label vareniclineRandomized pilot studySignificant health burdenComputer-generated tableTobacco pharmacotherapyHealth burdenQuit ratesPilot trialResearch clinicDrinking reductionsVareniclineBehavioural counsellingAlcohol treatmentCombined smokingMedium effect sizeSmokingSmokersCounsellingDrinking
2013
Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates
Leeman RF, Corbin WR, Fucito LM, Urwin JW, O’Malley S. Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates. Journal Of Addiction Research & Therapy 2013, 4: 151. PMID: 24511431, PMCID: PMC3917969, DOI: 10.4172/2155-6105.1000151.Peer-Reviewed Original ResearchClinical trialsPredictors of interestTrend-level predictorCurrent cigarette smokingNon-white raceCigarette smokingDrinking reductionsPast-year drinkersTreatment engagementHeavy drinkersReduction messagesAlcohol-related negative consequencesYoung adultsSignificant predictorsTrialsNaltrexonePredictorsRandom sampleDrinkersRegression modelsFull regression modelCounselingEquivalent levelsHigher numberMedications